| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.29 | 1e-09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.056 | 0.3 |